Juvenile Arthritis Helped by Adult Meds

JUNE 01, 2005

A recent study in the New England Journal of Medicine touted the efficacy of adult arthritis drugs methotrexate and leflunomide (Arava) in treating children with arthritis. Whereas methotrexate has been used for years to treat children with arthritis, it now has been shown to be effective at higher doses. The FDA has approved Arava for adult use but not for treating children.

Patients given the higher dose of methotrexate had a 90% response rate, while patients taking Arava had a 68% response rate. Both drugs help control the white blood cells that cause inflammation and pain associated with arthritis. The study was funded by Sanofi-Aventis, manufacturer of both drugs.



SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.